| Holder | Position | Change | Date | |
|---|---|---|---|---|
| Citadel Advisors LLC | 0.6% | 0 | 03-Dec-2025 | View History |
| Marshall Wace LLP | 0.68% | 0 | 28-Nov-2025 | View History |
| Holocene Advisors LP | 0.7% | 0 | 17-Nov-2025 | View History |
| Millennium International Management LP | 0.6% | 0 | 17-Nov-2025 | View History |
| AKO Capital LLP | 0.73% | 0 | 06-Jun-2025 | View History |
Smith & Nephew is a British medical technology company that develops, manufactures, and sells medical devices. Products include arthroscopy, trauma, clinical therapy, and orthopaedic reconstruction products. Smith & Nephew's products are sold in over 100 countries, including Europe, the Americas, Asia Pacific, the Middle East, and Africa.
Smith & Nephew operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
Smith & Nephew's shares are traded in London and New York, and the company is a constituent of the UK's FTSE100.
Smith and Nephew share price launched at 182p in 1988.